{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["Not provided"],"condition":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2159360"],"study_start_month":["Not provided"],"keyword":["Capecitabine"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker","description":"Colorectal cancer patients with metastases (mCRC) at response under first-line chemotherapy are candidates for an convenient maintenance treatment.","dates":{"creation":"1900-01-01"},"accession":"2159360","cross_references":{"ClinicalTrials___gov":["NCT02043821"]}}